Cargando…

Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients

BACKGROUND: Cardiac allograft vasculopathy (CAV) remains the Achilles' heel of long-term survival after heart transplantation (HTx). The severity and extent of CAV is graded with conventional coronary angiography (COR) which has several limitations. Recently, vessel fractional flow reserve (vFF...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagumo, Sakura, Gallinoro, Emanuele, Candreva, Alessandro, Mizukami, Takuya, Monizzi, Giovanni, Kodeboina, Monika, Verstreken, Sofie, Dierckx, Riet, Heggermont, Ward, Bartunek, Jozef, Goethals, Marc, Buytaert, Dimitri, De Bruyne, Bernard, Sonck, Jeroen, Collet, Carlos, Vanderheyden, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376430/
https://www.ncbi.nlm.nih.gov/pubmed/32733172
http://dx.doi.org/10.1155/2020/9835151
_version_ 1783562043581792256
author Nagumo, Sakura
Gallinoro, Emanuele
Candreva, Alessandro
Mizukami, Takuya
Monizzi, Giovanni
Kodeboina, Monika
Verstreken, Sofie
Dierckx, Riet
Heggermont, Ward
Bartunek, Jozef
Goethals, Marc
Buytaert, Dimitri
De Bruyne, Bernard
Sonck, Jeroen
Collet, Carlos
Vanderheyden, Marc
author_facet Nagumo, Sakura
Gallinoro, Emanuele
Candreva, Alessandro
Mizukami, Takuya
Monizzi, Giovanni
Kodeboina, Monika
Verstreken, Sofie
Dierckx, Riet
Heggermont, Ward
Bartunek, Jozef
Goethals, Marc
Buytaert, Dimitri
De Bruyne, Bernard
Sonck, Jeroen
Collet, Carlos
Vanderheyden, Marc
author_sort Nagumo, Sakura
collection PubMed
description BACKGROUND: Cardiac allograft vasculopathy (CAV) remains the Achilles' heel of long-term survival after heart transplantation (HTx). The severity and extent of CAV is graded with conventional coronary angiography (COR) which has several limitations. Recently, vessel fractional flow reserve (vFFR) derived from COR has emerged as a diagnostic computational tool to quantify the functional severity of coronary artery disease. PURPOSE: The present study assessed the usefulness of vFFR to detect CAV in HTx recipients. METHODS: In HTx patients referred for annual check-up, undergoing surveillance COR, the extent of CAV was graded according to the criteria proposed by the international society of heart and lung transplantation (ISHLT). In addition, three-dimensional coronary geometries were constructed from COR to calculate pressure losses using vFFR. RESULTS: In 65 HTx patients with a mean age of 53.7 ± 10.1 years, 8.5 years (IQR 1.90, 15.2) years after HTx, a total number of 173 vessels (59 LAD, 61 LCX, and 53 RCA) were analyzed. The mean vFFR was 0.84 ± 0.15 and median was 0.88 (IQR 0.79, 0.94). A vFFR ≤ 0.80 was present in 24 patients (48 vessels). HTx patients with a history of ischemic cardiomyopathy (ICMP) had numerically lower vFFR as compared to those with non-ICMP (0.70 ± 0.22 vs. 0.79 ± 0.13, p = 0.06). The use of vFFR reclassified 31.9% of patients compared to the anatomical ISHLT criteria. Despite a CAV score of 0, a pathological vFFR ≤ 0.80 was detected in 8 patients (34.8%). CONCLUSION: The impairment in epicardial conductance assessed by vFFR in a subgroup of patients without CAV according to standard ISHLT criteria suggests the presence of a diffuse vasculopathy undetectable by conventional angiography. Therefore, we speculate that vFFR may be useful in risk stratification after HTx.
format Online
Article
Text
id pubmed-7376430
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-73764302020-07-29 Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients Nagumo, Sakura Gallinoro, Emanuele Candreva, Alessandro Mizukami, Takuya Monizzi, Giovanni Kodeboina, Monika Verstreken, Sofie Dierckx, Riet Heggermont, Ward Bartunek, Jozef Goethals, Marc Buytaert, Dimitri De Bruyne, Bernard Sonck, Jeroen Collet, Carlos Vanderheyden, Marc J Interv Cardiol Research Article BACKGROUND: Cardiac allograft vasculopathy (CAV) remains the Achilles' heel of long-term survival after heart transplantation (HTx). The severity and extent of CAV is graded with conventional coronary angiography (COR) which has several limitations. Recently, vessel fractional flow reserve (vFFR) derived from COR has emerged as a diagnostic computational tool to quantify the functional severity of coronary artery disease. PURPOSE: The present study assessed the usefulness of vFFR to detect CAV in HTx recipients. METHODS: In HTx patients referred for annual check-up, undergoing surveillance COR, the extent of CAV was graded according to the criteria proposed by the international society of heart and lung transplantation (ISHLT). In addition, three-dimensional coronary geometries were constructed from COR to calculate pressure losses using vFFR. RESULTS: In 65 HTx patients with a mean age of 53.7 ± 10.1 years, 8.5 years (IQR 1.90, 15.2) years after HTx, a total number of 173 vessels (59 LAD, 61 LCX, and 53 RCA) were analyzed. The mean vFFR was 0.84 ± 0.15 and median was 0.88 (IQR 0.79, 0.94). A vFFR ≤ 0.80 was present in 24 patients (48 vessels). HTx patients with a history of ischemic cardiomyopathy (ICMP) had numerically lower vFFR as compared to those with non-ICMP (0.70 ± 0.22 vs. 0.79 ± 0.13, p = 0.06). The use of vFFR reclassified 31.9% of patients compared to the anatomical ISHLT criteria. Despite a CAV score of 0, a pathological vFFR ≤ 0.80 was detected in 8 patients (34.8%). CONCLUSION: The impairment in epicardial conductance assessed by vFFR in a subgroup of patients without CAV according to standard ISHLT criteria suggests the presence of a diffuse vasculopathy undetectable by conventional angiography. Therefore, we speculate that vFFR may be useful in risk stratification after HTx. Hindawi 2020-07-12 /pmc/articles/PMC7376430/ /pubmed/32733172 http://dx.doi.org/10.1155/2020/9835151 Text en Copyright © 2020 Sakura Nagumo et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nagumo, Sakura
Gallinoro, Emanuele
Candreva, Alessandro
Mizukami, Takuya
Monizzi, Giovanni
Kodeboina, Monika
Verstreken, Sofie
Dierckx, Riet
Heggermont, Ward
Bartunek, Jozef
Goethals, Marc
Buytaert, Dimitri
De Bruyne, Bernard
Sonck, Jeroen
Collet, Carlos
Vanderheyden, Marc
Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
title Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
title_full Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
title_fullStr Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
title_full_unstemmed Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
title_short Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
title_sort vessel fractional flow reserve and graft vasculopathy in heart transplant recipients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376430/
https://www.ncbi.nlm.nih.gov/pubmed/32733172
http://dx.doi.org/10.1155/2020/9835151
work_keys_str_mv AT nagumosakura vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT gallinoroemanuele vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT candrevaalessandro vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT mizukamitakuya vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT monizzigiovanni vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT kodeboinamonika vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT verstrekensofie vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT dierckxriet vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT heggermontward vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT bartunekjozef vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT goethalsmarc vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT buytaertdimitri vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT debruynebernard vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT sonckjeroen vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT colletcarlos vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients
AT vanderheydenmarc vesselfractionalflowreserveandgraftvasculopathyinhearttransplantrecipients